---
schema_version: "secwatch.filing_event.v1"
accession: "0000010795-24-000024"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2024-02-27T23:59:59+00:00"
generated_at: "2026-06-05T10:35:37.940394+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BD Life Sciences President Dave Hickey to retire effective July 1, 2024

## Summary
- Dave Hickey, EVP and President of Life Sciences segment, announced retirement effective July 1, 2024.
- Hickey held the role since January 2021; previously president of Integrated Diagnostic Solutions and Diagnostic Systems.
- BD intends to name a successor prior to his retirement date.
- Hickey joined BD in 2014 and led development of rapid and molecular COVID-19 diagnostic tests.
- No financial or guidance changes disclosed in connection with the retirement.

## SEC filing metadata
- accession: 0000010795-24-000024
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2024-02-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000001079524000024/0000010795-24-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000001079524000024/bdx-20240222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000010795-24-000024
- JSON: https://secwatch.observer/filing/0000010795-24-000024.json
- Plain text: https://secwatch.observer/filing/0000010795-24-000024.txt

## Key facts
- Executive change
  David Hickey departed as Executive Vice President and President of the Life Sciences segment at BECTON DICKINSON & CO.
  - Action: retire
  - Role: Executive Vice President and President of the Life Sciences segment
  source text: On February 22, 2024, David Hickey, Executive Vice President and President of the Life Sciences segment of Becton, Dickinson and Company ("BD"), informed BD of his intention to retire, effective July 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/10795/000001079524000024/0000010795-24-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.